ema-register

Crysvita is an antibody for a rare bone-softening condition in which the body leaks phosphate. Some small tumours cause it by making too much of a hormone called FGF23; when the tumour cannot be found or removed, Crysvita blocks the hormone.

Enrylaze is a replacement asparaginase for children and adults with acute lymphoblastic leukaemia or lymphoblastic lymphoma whose bodies have reacted against, or quietly neutralised, the usual E. coli asparaginase. It keeps the asparagine-starving part of their chemotherapy going.

Lynkuet is a once-a-day capsule for moderate to severe hot flushes and night sweats. In Europe it is approved both for the menopause and for hot flushes caused by the hormone-blocking tablets taken after breast cancer treatment.

NeoRecormon is a man-made copy of erythropoietin, the hormone that tells the marrow to make red blood cells. In cancer care it treats anaemia that is causing symptoms in adults having chemotherapy for cancers that do not start in the marrow's myeloid cells.

Epoetin theta is a made-to-order version of erythropoietin, the hormone that tells the marrow to make red blood cells. It is used to treat the anaemia of chemotherapy in people with non-myeloid cancers, sparing some transfusions.

These are fast-acting forms of the opioid fentanyl, taken as a tablet against the cheek or as a nasal spray, for sudden flares of pain in people whose cancer pain is otherwise controlled by a regular opioid. They are only for patients already tolerant to opioids.

SomaKit TOC is a kit used to make a radioactive tracer for a PET scan in adults known or thought to have a neuroendocrine tumour of the gut or pancreas. The tracer sticks to the tumour cells so the scan can show where the tumour started and where it has spread.

Intravenous immunoglobulin is pooled antibody from many blood donors. People with chronic lymphocytic leukaemia or myeloma whose own antibody levels have collapsed, and who keep getting bacterial infections despite antibiotics, receive it as replacement.

Lumeblue is a blue dye taken as tablets the day before a colonoscopy. It stains the lining of the bowel so that the doctor can see polyps and early cancers more easily during screening or follow-up.

Resminostat is an oral drug of the HDAC inhibitor class, proposed for advanced mycosis fungoides and Sézary syndrome, two cutaneous T-cell lymphomas. Europe's medicines committee said no to it in May 2025, so it is not authorised.

Tacquell is a tumour-infiltrating lymphocyte therapy for melanoma developed by the Netherlands Cancer Institute, the academic group whose randomised trial first showed TIL therapy could beat ipilimumab. Europe's medicines committee gave it a negative opinion in June 2026, so it is not authorised.